Tidal Investments LLC Grows Stock Position in Pediatrix Medical Group, Inc. $MD

Tidal Investments LLC increased its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 253.9% in the second quarter, HoldingsChannel reports. The fund owned 616,048 shares of the company’s stock after purchasing an additional 441,959 shares during the period. Tidal Investments LLC’s holdings in Pediatrix Medical Group were worth $15,604,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Global Retirement Partners LLC grew its position in Pediatrix Medical Group by 68,250.0% during the 4th quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock worth $29,000 after acquiring an additional 1,365 shares during the last quarter. Transamerica Financial Advisors LLC purchased a new position in Pediatrix Medical Group in the 4th quarter worth approximately $30,000. Eurizon Capital SGR S.p.A. bought a new stake in Pediatrix Medical Group in the fourth quarter valued at approximately $33,000. Nykredit A S bought a new stake in Pediatrix Medical Group in the second quarter valued at approximately $35,000. Finally, TD Private Client Wealth LLC purchased a new stake in shares of Pediatrix Medical Group during the fourth quarter valued at approximately $39,000. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $25.00 target price on shares of Pediatrix Medical Group in a report on Wednesday, August 5th. Truist Financial upped their price target on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. UBS Group increased their price target on shares of Pediatrix Medical Group from $25.00 to $28.00 and gave the company a “neutral” rating in a research report on Thursday, August 6th. Wall Street Zen lowered shares of Pediatrix Medical Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 5th. Finally, Weiss Ratings upgraded shares of Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $26.60.

Pediatrix Medical Group Price Performance

MD opened at $26.68 on Friday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.32 and a current ratio of 1.32. The stock has a market capitalization of $2.17 billion, a PE ratio of 12.77 and a beta of 0.64. The stock’s 50 day moving average price is $26.42 and its 200-day moving average price is $23.57. Pediatrix Medical Group, Inc. has a 52-week low of $15.69 and a 52-week high of $27.94.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, topping analysts’ consensus estimates of $0.59 by $0.04. The company had revenue of $487.78 million during the quarter, compared to analyst estimates of $478.49 million. Pediatrix Medical Group had a return on equity of 20.05% and a net margin of 8.96%.The firm’s revenue was up 4.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.53 earnings per share. On average, equities research analysts predict that Pediatrix Medical Group, Inc. will post 2.17 EPS for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.